RT Journal Article
SR Electronic
T1 Mortality Associated With Intubation and Mechanical Ventilation in Patients with COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.13.20174524
DO 10.1101/2020.08.13.20174524
A1 Patrick W. Zimmerman
A1 Stephanie J. Stroever
A1 Timothy Burton
A1 Karri E. Hester
A1 Minha Kim
A1 Ryan T. Fahy
A1 Kimberly A. Corbitt
A1 Joann R. Petrini
A1 Jeffrey Nicastro
YR 2020
UL http://medrxiv.org/content/early/2020/08/15/2020.08.13.20174524.abstract
AB Objective The need for critical care, hemodynamic support, renal replacement therapy, and mechanical ventilation have emerged as key features of the SARS-nCoV-2 (COVID-19) pandemic. The primary aim of this study was to determine the in-hospital mortality rate of mechanically ventilated patients. We also sought to determine the risk of in-hospital mortality by age, gender, race, ethnicity, and body mass index.Methods We performed a retrospective cohort study to determine the mortality rate among inpatient adults with COVID-19 on mechanical ventilation in the Nuvance Health system between March 1, 2020 and July 17, 2020. Patients were included if they were 18 years or older, had a laboratory confirmed COVID-19 diagnosis, were admitted to hospitals within the Nuvance Health network (7 hospitals), and were on mechanical ventilation at any time during their inpatient stay.Results Overall mortality in our cohort of 304 patients was 53.3%. Multivariable logistic regression including age, gender, race, ethnicity, and BMI demonstrated patients over 71 years old had greater risk of mortality compared to patients ages 61-70, and females had half the risk compared to males. There was no significant difference in risk of mortality given race, ethnicity, or BMI.Conclusions In adult patients with confirmed COVID-19 infection requiring mechanical ventilation and intensive care, advanced age (>71 years old) and male gender are associated with increased risk of mortality. This information contributes to a collective body of evidence to support ongoing planning and decision-making among clinicians and for directed infection prevention programming.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThere was no external funding provided for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Biomedical Research Alliance of New York Institutional Review Board (IRB # 20-12-108-337(c20)) and the Vassar Brothers Medical Center Institutional Review Board (DCR# 2020-2). The study was approved as exempt under category #4(iii) as detailed in 45 CFR 46.104(d) as secondary research for which consent is not required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available upon request to the corresponding author.